NCT01838200 2022-10-12
Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
Ludwig Institute for Cancer Research
Phase 1 Terminated
Ludwig Institute for Cancer Research
AVAX Technologies